Brooklyn Investment Group Buys 80 Shares of Waters Co. (NYSE:WAT)

Brooklyn Investment Group increased its stake in shares of Waters Co. (NYSE:WAT) by 28.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 362 shares of the medical instruments supplier’s stock after purchasing an additional 80 shares during the quarter. Brooklyn Investment Group’s holdings in Waters were worth $134,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of WAT. Federated Hermes Inc. acquired a new stake in shares of Waters in the 2nd quarter valued at $59,000. Envestnet Asset Management Inc. boosted its holdings in Waters by 21.2% in the second quarter. Envestnet Asset Management Inc. now owns 105,171 shares of the medical instruments supplier’s stock valued at $30,512,000 after acquiring an additional 18,431 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Waters by 21.0% in the second quarter. Dimensional Fund Advisors LP now owns 448,304 shares of the medical instruments supplier’s stock valued at $130,053,000 after acquiring an additional 77,951 shares during the last quarter. Edgestream Partners L.P. increased its position in Waters by 523.5% in the second quarter. Edgestream Partners L.P. now owns 5,113 shares of the medical instruments supplier’s stock worth $1,483,000 after purchasing an additional 4,293 shares during the period. Finally, Argent Trust Co raised its holdings in Waters by 4.3% during the 2nd quarter. Argent Trust Co now owns 1,010 shares of the medical instruments supplier’s stock worth $293,000 after purchasing an additional 42 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Down 0.4 %

Shares of WAT stock opened at $403.85 on Friday. The company has a market capitalization of $23.98 billion, a price-to-earnings ratio of 38.54, a P/E/G ratio of 6.66 and a beta of 1.01. Waters Co. has a 12-month low of $279.24 and a 12-month high of $411.58. The firm has a fifty day moving average of $378.42 and a 200-day moving average of $350.18. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT) last released its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to the consensus estimate of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $2.84 EPS. As a group, equities research analysts predict that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WAT has been the subject of several analyst reports. Scotiabank began coverage on shares of Waters in a research report on Monday, December 23rd. They set a “sector perform” rating and a $430.00 price target for the company. Cfra set a $389.00 target price on shares of Waters in a report on Thursday, October 17th. TD Cowen increased their price target on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective for the company in a research note on Friday, January 10th. Finally, Evercore ISI increased their target price on Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $384.71.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.